Growing the Next Generation of Oncology Researchers and Oncologists

Gabrielle B Rocque^{1

2

3}, Stephanie B Wheeler^{4

5}, Jennifer Griggs⁶

Affiliations

¹ University of Alabama at Birmingham, Department of Medicine, Division of Hematology and Oncology, Birmingham, AL.
² University of Alabama at Birmingham, Department of Medicine, Division of Gerontology, Geriatrics, and Palliative Care, Birmingham, AL.
³ O'Neal Comprehensive Cancer Center, Birmingham, AL.
⁴ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
⁵ Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
⁶ University of Michigan, Ann Arbor, MI.

Editorial

Gabrielle B Rocque et al. JCO Oncol Pract. 2022 Aug.

. 2022 Aug;18(8):559-561.

doi: 10.1200/OP.21.00873. Epub 2022 Feb 14.

Gabrielle B Rocque^{1

2

3}, Stephanie B Wheeler^{4

5}, Jennifer Griggs⁶

¹ University of Alabama at Birmingham, Department of Medicine, Division of Hematology and Oncology, Birmingham, AL.
² University of Alabama at Birmingham, Department of Medicine, Division of Gerontology, Geriatrics, and Palliative Care, Birmingham, AL.
³ O'Neal Comprehensive Cancer Center, Birmingham, AL.
⁴ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
⁵ Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
⁶ University of Michigan, Ann Arbor, MI.

No abstract available

Figures

1. Williams CP, Davidoff AJ, Halpern MT, et al. Medication nonadherence and patient cost responsibility for rural and urban cancer survivors. J Clin Oncol. 2021;39 suppl 28, abstr 4. - PMC - PubMed
1. Kim IE, Kim DD, Kim S, et al. Abrogation of survival disparity between insured and uninsured individuals after the USPSTF's 2021 prostate-specific antigen-based prostate cancer screening recommendation. J Clin Oncol. 2021;39 (suppl 28, abstr 77) - PubMed
1. Jarnagin JX, Baiev I, Van Seventer EE, et al. Changes in patient-reported outcomes (PROs) and tumor markers (TMs) to predict response and survival in patients with metastatic gastrointestinal (GI) cancer. J Clin Oncol. 2021;39 (suppl 28; abstr 154)
1. Lawhon V, Caston NE, Smith KL, et al. Fear of COVID-19: Effects on metnal health in under-resources patients with cancer. J Clin Oncol. 2021;39 (suppl 28, abstr 152)
1. Franks J, Gidwani R, Enogela E, et al. Survival in the real world: A national analysis of patients treated for early-stage breast cancer. J Clin Oncol. 2021;29 (suppl 28, abstr 75) - PubMed